These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31383261)

  • 1. When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing.
    Brennan-Krohn T; Kirby JE
    Clin Lab Med; 2019 Sep; 39(3):345-358. PubMed ID: 31383261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Müderris T; Dursun Manyaslı G; Sezak N; Kaya S; Demirdal T; Gül Yurtsever S
    Eur J Med Res; 2024 Jun; 29(1):331. PubMed ID: 38880888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method.
    Brennan-Krohn T; Kirby JE
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
    Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
    J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii.
    March GA; Bratos MA
    J Microbiol Methods; 2015 Dec; 119():31-6. PubMed ID: 26415528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring.
    DeGirolami PC; Eliopoulos G
    Clin Lab Med; 1987 Sep; 7(3):499-512. PubMed ID: 3308291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and modelling of antibacterial combination regimens.
    Rao GG; Li J; Garonzik SM; Nation RL; Forrest A
    Clin Microbiol Infect; 2018 Jul; 24(7):689-696. PubMed ID: 29269090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.
    Bonapace CR; White RL; Friedrich LV; Bosso JA
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):43-50. PubMed ID: 11025183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.
    Coates ARM; Hu Y; Holt J; Yeh P
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):5-15. PubMed ID: 31847614
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H
    Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.
    Doern CD
    J Clin Microbiol; 2014 Dec; 52(12):4124-8. PubMed ID: 24920779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
    White RL; Burgess DS; Manduru M; Bosso JA
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1914-8. PubMed ID: 8843303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates.
    Zuo GY; Yang CX; Han J; Li YQ; Wang GC
    Phytomedicine; 2018 Jan; 39():93-99. PubMed ID: 29433688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4809-15. PubMed ID: 19704123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins.
    Wolska KI; Grześ K; Kurek A
    Pol J Microbiol; 2012; 61(2):95-104. PubMed ID: 23163208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CombiANT: Antibiotic interaction testing made easy.
    Fatsis-Kavalopoulos N; Roemhild R; Tang PC; Kreuger J; Andersson DI
    PLoS Biol; 2020 Sep; 18(9):e3000856. PubMed ID: 32941420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt.
    Nageeb W; Metwally L; Kamel M; Zakaria S
    J Infect Public Health; 2015; 8(6):593-602. PubMed ID: 26116454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.